Literature DB >> 2038116

The role of myocarditis and myocardial fibrosis in dilated cardiomyopathy. Analysis of 28 necropsy cases.

N Maehashi1, Y Yokota, A Takarada, S Usuki, S Maeda, H Yoshida, T Sugiyama, H Fukuzaki.   

Abstract

The hearts of 28 necropsy cases with DCM and 10 control cases were analysed to elucidate the role of myocarditis and fibrosis in dilated cardiomyopathy (DCM). The extent of fibrosis and myocyte diameter were measured in the transverse sections of the left ventricle. The degree and pattern of fibrosis varied widely from case to case. The DCM cases were then classified into 3 groups: 1) Group Ia, 8 cases with mild diffuse fibrosis; 2) Group Ib, 9 cases with severe diffuse fibrosis and 3) Group II, 11 cases with segmental fibrosis. Myocardial fibrosis and hypertrophy were significantly more prominent in Groups Ib and II than in the control group (p less than 0.01), but no differences were observed between Group Ia and the control group. Thus, it is reasonable to attribute the chronic CHF and LV dilatation in Groups Ib and II to the extensive myocardial fibrosis. In contrast, it is not reasonable to attribute the chronic CHF and LV dilatation in Group Ia to myocardial fibrosis. Focal lymphoid cell infiltration was graded to assess inflammatory changes. Group II showed more prominent inflammatory changes than the other 2 groups (p less than 0.05). Thus, it is possible that myocarditis is an etiologic factor for DCM with a segmental pattern of fibrosis.

Entities:  

Mesh:

Year:  1991        PMID: 2038116     DOI: 10.1536/ihj.32.1

Source DB:  PubMed          Journal:  Jpn Heart J        ISSN: 0021-4868


  7 in total

1.  Cardiovascular magnetic resonance tagging imaging correlates with myocardial dysfunction and T2 mapping in idiopathic dilated cardiomyopathy.

Authors:  Atsushi K Kono; Pierre Croisille; Tatsuya Nishii; Koya Nishiyama; Katsusuke Kyotani; Mayumi Shigeru; Sachiko Takamine; Sei Fujiwara; Kazuro Sugimura
Journal:  Int J Cardiovasc Imaging       Date:  2014-08-26       Impact factor: 2.357

2.  Assessment of myocardial fibrosis by endoventricular electromechanical mapping in experimental nonischemic cardiomyopathy.

Authors:  Peter J Psaltis; Angelo Carbone; Darryl P Leong; Dennis H Lau; Adam J Nelson; Tim Kuchel; Troy Jantzen; Jim Manavis; Kerry Williams; Prashanthan Sanders; Stan Gronthos; Andrew C W Zannettino; Stephen G Worthley
Journal:  Int J Cardiovasc Imaging       Date:  2010-06-29       Impact factor: 2.357

3.  Late gadolinium enhancement on cardiac magnetic resonance imaging: is it associated with a higher incidence of nonsustained ventricular tachycardia in patients with idiopathic dilated cardiomyopathy?

Authors:  Atsushi K Kono; Kazunari Ishii; Hiroyuki Kumagai; Yasuyo Taniguchi; Teishi Kajiya; Kazuro Sugimura
Journal:  Jpn J Radiol       Date:  2010-06-30       Impact factor: 2.374

4.  Myocardial electrical propagation in patients with idiopathic dilated cardiomyopathy.

Authors:  K P Anderson; R Walker; P Urie; P R Ershler; R L Lux; S V Karwandee
Journal:  J Clin Invest       Date:  1993-07       Impact factor: 14.808

5.  Delayed enhancement cardiac magnetic resonance imaging reveals typical patterns of myocardial injury in patients with various forms of non-ischemic heart disease.

Authors:  Steffen Bohl; Ralf Wassmuth; Hassan Abdel-Aty; André Rudolph; Daniel Messroghli; Rainer Dietz; Jeanette Schulz-Menger
Journal:  Int J Cardiovasc Imaging       Date:  2008-03-16       Impact factor: 2.357

6.  Evaluation of Modified Look-Locker Inversion Recovery and Arrhythmia-Insensitive Rapid Cardiac T1 Mapping Pulse Sequences in Cardiomyopathy Patients.

Authors:  Sean Robison; KyungPyo Hong; Daniel Kim; Rachel Lloyd; Jay Ramchand; Emma Hornsey; Piyush Srivastava; Gerard Smith; Leighton Kearney; Ruth Lim
Journal:  J Comput Assist Tomogr       Date:  2018 Sep/Oct       Impact factor: 1.826

7.  Mechanical effects of left ventricular midwall fibrosis in non-ischemic cardiomyopathy.

Authors:  Robin J Taylor; Fraz Umar; Erica L S Lin; Amar Ahmed; William E Moody; Wojciech Mazur; Berthold Stegemann; Jonathan N Townend; Richard P Steeds; Francisco Leyva
Journal:  J Cardiovasc Magn Reson       Date:  2016-01-05       Impact factor: 5.364

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.